Neion Bio Taps John Maga as Head of Biologics and CMC to Expand Capabilities In Innovative Development

Neion Bio announced the appointment of John A. Maga, Ph.D., as Head of Biologics and CMC. Maga brings over 25 years of biopharmaceutical experience, including 15 years at BioMarin Pharmaceutical. He will lead biologics development and expand Neion's Raptor platform capabilities for producing complex therapeutic proteins using transgenic chickens.